Global Citicoline Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Citicoline Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Citicoline (cytidine diphosphocholine, CDP-choline) is a novel nutrient with a broad spectrum of benefits for conditions associated with symptoms of neurological dysfunction. An endogenous compound, citicoline is an essential intermediate in the synthesis of cell membrane phospholipids and its formation is the rate-limiting step in phosphatidylcholine synthesis. It plays several important roles in human physiology, including enhancement of structural integrity and signaling for cell membranes, support of acetylcholine synthesis, and synthesis of betaine, a methyl donor. Citicoline provides the brain with a source of choline and cytidine, which are efficiently used in the Kennedy cycle to generate phospholipids. It is able to attenuate the production of free radicals in ischemic conditions, while it also stimulates glutathione synthesis and the activity of glutathione reductase. Studies in animals and humans provide evidence of citicoline’s ability to promote learning and memory and improve cognitive impairment in Alzheimer’s and Parkinson’s disease, as well as in victims of mild to moderate stroke and cerebral ischemia. Citicoline administration may also reduce the duration of coma and the severity of mental and motor deficits associated with traumatic head injuries.

As a medicine, it is taken by mouth as a supplement or given by IV or as a shot. Citicoline is used for Alzheimer"s disease and other types of dementia, head trauma, cerebrovascular disease such as stroke, age-related memory loss, Parkinson"s disease, attention deficit-hyperactive disorder (ADHD), and glaucoma.

Citicoline was originally developed in Japan for stroke. It was later introduced as a prescription drug in many European countries. In these countries it is now frequently prescribed for thinking problems related to circulation problems in the brain. In the US, citicoline is marketed as a dietary supplement.

According to our (Global Info Research) latest study, the global Citicoline market size was valued at US$ 352 million in 2023 and is forecast to a readjusted size of USD 876 million by 2030 with a CAGR of 14.1% during review period.

Global Citicoline key players include Union Korea Pharm, Century Pharma, Invision Medi Sciences, etc.

In terms of application, the largest application is Pharma, with a share over 85%, followed by Non-pharma.

This report is a detailed and comprehensive analysis for global Citicoline market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Citicoline market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Ton), 2019-2030

Global Citicoline market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Ton), 2019-2030

Global Citicoline market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Ton), 2019-2030

Global Citicoline market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (USD/Ton), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Citicoline

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Citicoline market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Union Korea Pharm, Century Pharma, Invision Medi Sciences, Rasco Life Sciences, RPG Life Sciences Ltd, Chemo Biological, Harbin Pharm. Group Sanjing Pharmaceutical, Innova, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Citicoline market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Injection
Tablets
Capsule

Market segment by Application
Pharma
Non-pharma

Major players covered
Union Korea Pharm
Century Pharma
Invision Medi Sciences
Rasco Life Sciences
RPG Life Sciences Ltd
Chemo Biological
Harbin Pharm. Group Sanjing Pharmaceutical
Innova

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Citicoline product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Citicoline, with price, sales quantity, revenue, and global market share of Citicoline from 2019 to 2024.

Chapter 3, the Citicoline competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Citicoline breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Citicoline market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Citicoline.

Chapter 14 and 15, to describe Citicoline sales channel, distributors, customers, research findings and conclusion.